Skye Drynan
Fortune : - $ au 31/07/2026
Fortune : - $ au 31/07/2026
Skye Yayoi Drynan is the founder of House of Skye LTD, founded in 2016, serving as Chief Executive Officer & Creative Director since 2020.
The current job is Independent Director at Gossamer Bio, Inc. starting in 2024.
Former jobs include Research Analyst at Lord, Abbett & Co. LLC in 2007; Analyst at Putnam LLC; Analyst at Credit Suisse Asset Management LLC; Analyst at Capital Guardian Trust Co.; Vice President at New Vernon Associates, Inc.; Principal at Whitehead Institute for Biomedical Research; and Analyst at Capital Research & Management Co. (International Investors) from 2008 to 2020.
Education includes undergraduate studies at Wellesley College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GOSSAMER BIO, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GOSSAMER BIO, INC. | Directeur/Membre du Conseil | 11/03/2024 |
House of Skye LTD | Directeur Général | 01/01/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Capital Research & Management Co. (International Investors)
Capital Research & Management Co. (International Investors) Investment ManagersFinance CRMC's International Investors division invests primarily in the stocks of large-cap growth-oriented companies across practically all sectors. The firm typically builds portfolios for funds and accounts from the bottom-up using rigorous fundamental research to find attractive investments and manage risks. Although they invest internationally, most of their investments are in the stocks of North American companies. CRMC maintains an investment philosophy that is distinguished by four key beliefs: (1) solid research is fundamental to sound investment decisions; (2) investment decisions should not be made lightly; (3) a long-term approach; (4) the capital system. | Analyst-Equity | 01/10/2020 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Corporate Officer/Principal | - |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance CSAM aims to drive long-term performance and positive impact beyond returns. | Corporate Officer/Principal | - |
Putnam LLC
Putnam LLC Investment ManagersFinance Provides financial services | Corporate Officer/Principal | - |
New Vernon Associates, Inc.
New Vernon Associates, Inc. Investment ManagersFinance Provides investment research | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Lord, Abbett & Co. LLC
Lord, Abbett & Co. LLC Investment ManagersFinance Lord Abbett manages equity, fixed income, and multi-asset class portfolios across a wide range of investment strategies. Portfolio management teams employ a rigorous investment approach, and the firm’s investment processes are supported by a strong internal focus on fundamental and quantitative research. | Finance |
Putnam LLC
Putnam LLC Investment ManagersFinance Provides financial services | Finance |
Credit Suisse Asset Management LLC
Credit Suisse Asset Management LLC Investment ManagersFinance CSAM aims to drive long-term performance and positive impact beyond returns. | Finance |
Capital Guardian Trust Co.
Capital Guardian Trust Co. Investment ManagersFinance CGTC employs a long-term investment approach that is based on rigorous fundamental research. The firm uses a system of multiple portfolio managers in managing most separate account and fund assets. Under this approach, the portfolio of an account or fund is divided into segments managed by individual managers who decide how their respective segments will be invested. In addition, investment analysts may make investment decisions with respect to a portion of the portfolio. The firm offers equity, fixed-income, balanced, and other customized investment strategies based on the investment objectives of CGTC clients. CGTC's equity strategies include: US Equity, International Equity, Global Equity, All Country World Equity, International All Countries Equity, and Emerging Markets Equity. The firm's fixed-income strategies include: US Core Fixed-Income, Long Duration Government, Long Duration Credit, US High-Yield, International Fixed-Income, Global Fixed-Income, Global High-Income Opportunities, and Emerging Markets Debt. CGTC's balanced and total opportunities strategies include: US Balanced, Global Balanced, Absolute Income Grower, World Dividend Growers, and Emerging Markets Total Opportunities. | Finance |
New Vernon Associates, Inc.
New Vernon Associates, Inc. Investment ManagersFinance Provides investment research | Finance |
Wellesley College
Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Capital Research & Management Co. (International Investors)
Capital Research & Management Co. (International Investors) Investment ManagersFinance CRMC's International Investors division invests primarily in the stocks of large-cap growth-oriented companies across practically all sectors. The firm typically builds portfolios for funds and accounts from the bottom-up using rigorous fundamental research to find attractive investments and manage risks. Although they invest internationally, most of their investments are in the stocks of North American companies. CRMC maintains an investment philosophy that is distinguished by four key beliefs: (1) solid research is fundamental to sound investment decisions; (2) investment decisions should not be made lightly; (3) a long-term approach; (4) the capital system. | Finance |
Gossamer Bio, Inc.
Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
House of Skye LTD |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national